Voting rights: BB Medtech AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution

BB Medtech AG / Voting rights: Announcement pursuant to article 26
sec 1 WpHG

Publication pursuant to §26 sect.1 WpHG (the German Securities
Trading Act) processed and transmitted by Hugin. The issuer is solely
responsible for the content of this announcement.

----------------------------------------------------------------------
--------------

Disclosure of shareholdings

Pursuant to article 21 sec 1 WpHG, Bellevue Group AG, 8700 Küsnacht,
Switzerland, has announced on March 10, 2009, to
BB MEDTECH AG, 8200 Schaffhausen, Switzerland, that its holding in
registered shares BB MEDTECH AG decreased to below 5% and 3%
respectively of the proportion of voting rights (0 voting rights /
0.00%).

For further information please contact:
Bellevue Asset Management AG, Seestrasse 16, CH-8700 Küsnacht/Zürich
Anja Stubenrauch or Michael Hutter, Tel. +41 44 267 67 00.

Company profile
BB MEDTECH acquires shares in companies in the growth market of
medical technology. BB MEDTECH is listed on the Swiss Stock Exchange
and in Germany. The focus of the shareholdings is on listed companies
that are taking on a market leadership role in their area of
activities and demonstrate sustained turnover and income potential.
For its selection of holdings, BB MEDTECH relies on fundamental
analysis by industry experts. The Board of Directors has many years
of industrial and scientific experience behind it.

--- End of Message ---

BB Medtech AG
Vordergasse 3 Schaffhausen Switzerland

WKN: 898194 ;
ISIN: CH0000428661; Index: TECH All Share, TecDAX, Prime All Share;
Listed: Prime Standard in Frankfurter Wertpapierbörse, Regulierter
Markt in Frankfurter Wertpapierbörse;
Copyright © Hugin AS 2009. All rights reserved.